Background Evidence‐based therapies are generally underused for cardiovascular risk
reduction; however, less is known about contemporary patients with type 2 diabetes mellitus …

Importance Based on contemporary estimates in the US, evidence-based therapies for
cardiovascular risk reduction are generally underused among patients with type 2 diabetes …

BACKGROUND: Results from the COORDINATE-Diabetes trial (Coordinating Cardiology
Clinics Randomized Trial of Interventions to Improve Outcomes-Diabetes) demonstrated that …

BACKGROUND: Type 2 diabetes mellitus (T2DM) is a chronic condition with a high
economic burden as well as drug treatments that have not all demonstrated effects on …

Importance Evidence-based therapies to reduce atherosclerotic cardiovascular disease risk
in adults with type 2 diabetes are underused in clinical practice. Objective To assess the …

Research evidence is necessary but insufficient for making patient care decisions. An
effective but toxic chemotherapeutic regimen is the treatment one patient with cancer can …

Aims/hypothesis Clinical trials assessing interventions for treating and preventing diabetes
mellitus and its complications are needed to inform evidence-based practice. To examine …

BACKGROUND: Diabetic patients have a higher rate of recurrent cardiovascular events and
death than nondiabetic individuals. Although partially attributable to lower use of evidence …

The American College of Cardiology (ACC) develops a wide range of policy documents to
provide members with guidance on clinical topics. Although Clinical Practice Guidelines …

OBJECTIVE—Improving diabetes care in the US is critical because diabetes rates are
increasing dramatically, particularly among minority and low-income populations. Although …